Investigational Drug Information for Vorasidenib
✉ Email this page to a colleague
What is the drug development status for Vorasidenib?
Vorasidenib is an investigational drug.
There have been 6 clinical trials for Vorasidenib.
The most recent clinical trial was a Phase 1 trial, which was initiated on January 5th 2020.
The most common disease conditions in clinical trials are Glioma, Liver Diseases, and Astrocytoma. The leading clinical trial sponsors are Institut de Recherches Internationales Servier, Agios Pharmaceuticals, Inc., and Merck Sharp & Dohme LLC.
There are six US patents protecting this investigational drug and eighty-four international patents.
Summary for Vorasidenib
| US Patents | 6 |
| International Patents | 84 |
| US Patent Applications | 28 |
| WIPO Patent Applications | 6 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 1 (2020-01-05) |
| Vendors | 40 |
Recent Clinical Trials for Vorasidenib
| Title | Sponsor | Phase |
|---|---|---|
| A Phase 1, Open-Label Study to Evaluate the Effect of a Low-Fat Meal and Multiple Doses of Ciprofloxacin on the Pharmacokinetics of Vorasidenib in Healthy Subjects | Institut de Recherches Internationales Servier | Phase 1 |
| A Phase 1, Open-Label Study to Evaluate the Effect of a Low-Fat Meal and Multiple Doses of Ciprofloxacin on the Pharmacokinetics of Vorasidenib in Healthy Subjects | Servier Bio-Innovation LLC | Phase 1 |
| A Study of Vorasidenib in Participants With Moderate or Mild Hepatic Impairment and Matched Participants With Normal Hepatic Function | Institut de Recherches Internationales Servier | Phase 1 |
Clinical Trial Summary for Vorasidenib
Top disease conditions for Vorasidenib
Top clinical trial sponsors for Vorasidenib
US Patents for Vorasidenib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Vorasidenib | ⤷ Try a Trial | Therapeutically active compounds and their methods of use | Agios Pharmaceuticals, Inc. (Cambridge, MA) | ⤷ Try a Trial |
| Vorasidenib | ⤷ Try a Trial | Therapeutically active compounds and their methods of use | Agios Pharmaceuticals, Inc. (Cambridge, MA) | ⤷ Try a Trial |
| Vorasidenib | ⤷ Try a Trial | Methods of treating brain tumors using combination therapy | Agios Pharmaceuticals, Inc. (Cambridge, MA) | ⤷ Try a Trial |
| Vorasidenib | ⤷ Try a Trial | ⤷ Try a Trial | ||
| Vorasidenib | ⤷ Try a Trial | Therapeutically active compounds and their methods of use | AGIOS PHARMACEUTICALS, INC (Cambridge, MA) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Vorasidenib
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Vorasidenib | Argentina | AR096902 | 2033-07-11 | ⤷ Try a Trial |
| Vorasidenib | Australia | AU2014289744 | 2033-07-11 | ⤷ Try a Trial |
| Vorasidenib | Australia | AU2019201179 | 2033-07-11 | ⤷ Try a Trial |
| Vorasidenib | Brazil | BR112016000561 | 2033-07-11 | ⤷ Try a Trial |
| Vorasidenib | Brazil | BR122017014843 | 2033-07-11 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
